These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36867178)

  • 21. ACP Journal Club. In older adults with treatment-resistant depression, adding aripiprazole to venlafaxine increased remission at 12 wk.
    Hategan A
    Ann Intern Med; 2016 Jan; 164(2):JC10. PubMed ID: 26784490
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment-resistant depression in later life.
    El Bayoumi H; Ismail Z
    J Psychiatry Neurosci; 2015 Nov; 40(6):E34-5. PubMed ID: 26513542
    [No Abstract]   [Full Text] [Related]  

  • 23. Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial.
    McAllister-Williams RH; Anderson IM; Finkelmeyer A; Gallagher P; Grunze HC; Haddad PM; Hughes T; Lloyd AJ; Mamasoula C; McColl E; Pearce S; Siddiqi N; Sinha BN; Steen N; Wainwright J; Winter FH; Ferrier IN; Watson S;
    Lancet Psychiatry; 2016 Feb; 3(2):117-27. PubMed ID: 26727041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting Remission in Late-Life Major Depression: A Clinical Algorithm Based Upon Past Treatment History.
    Buchalter ELF; Oughli HA; Lenze EJ; Dixon D; Miller JP; Blumberger DM; Karp JF; Reynolds CF; Mulsant BH
    J Clin Psychiatry; 2019 Dec; 80(6):. PubMed ID: 31846575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder.
    Smagula SF; Wallace ML; Anderson SJ; Karp JF; Lenze EJ; Mulsant BH; Butters MA; Blumberger DM; Diniz BS; Lotrich FE; Dew MA; Reynolds CF
    J Psychiatr Res; 2016 Oct; 81():112-8. PubMed ID: 27438687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmentation of Sevoflurane inhalation for treatment-resistant depression with different features: A case series.
    Feng M; Cheng S; Fang Y; Lv L; Guo P; Wang S; Chen H
    Asian J Psychiatr; 2023 Apr; 82():103495. PubMed ID: 36739717
    [No Abstract]   [Full Text] [Related]  

  • 27. [Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy].
    Erbe S; Gutwinski S; Bschor T
    Psychiatr Prax; 2012 Mar; 39(2):57-63. PubMed ID: 22189902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral ketamine augmentation for chronic suicidality in treatment-resistant depression.
    De Gioannis A; De Leo D
    Aust N Z J Psychiatry; 2014 Jul; 48(7):686. PubMed ID: 24452289
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparing Cost-Effectiveness of Aripiprazole Augmentation With Other "Next-Step" Depression Treatment Strategies: A Randomized Clinical Trial.
    Yoon J; Zisook S; Park A; Johnson GR; Scrymgeour A; Mohamed S
    J Clin Psychiatry; 2018 Dec; 80(1):. PubMed ID: 30695291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study).
    Fava M; Mischoulon D; Iosifescu D; Witte J; Pencina M; Flynn M; Harper L; Levy M; Rickels K; Pollack M
    Psychother Psychosom; 2012; 81(2):87-97. PubMed ID: 22286203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An open trial of aripiprazole augmentation for SSRI non-remitters with late-life depression.
    Rutherford B; Sneed J; Miyazaki M; Eisenstadt R; Devanand D; Sackeim H; Roose S
    Int J Geriatr Psychiatry; 2007 Oct; 22(10):986-91. PubMed ID: 17340654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low- and high-dose aripiprazole augmentation and plasma levels of homovanillic acid in major depressive disorder: A randomized, open-label study.
    Horikoshi S; Miura I; Ichinose M; Yamamoto S; Ito M; Watanabe K; Kanno-Nozaki K; Kaneko H; Yabe H
    Hum Psychopharmacol; 2019 May; 34(3):e2696. PubMed ID: 31044463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder.
    Simon JS; Nemeroff CB
    J Clin Psychiatry; 2005 Oct; 66(10):1216-20. PubMed ID: 16259533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment response of lithium augmentation in geriatric compared to non-geriatric patients with treatment-resistant depression.
    Buspavanich P; Behr J; Stamm T; Schlattmann P; Bschor T; Richter C; Hellweg R; Heinz A; Berger M; Hindinger C; Rentzsch J; de Millas W; Jockers-Scherübl MC; Bräunig P; Adli M; Ricken R
    J Affect Disord; 2019 May; 251():136-140. PubMed ID: 30921597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Is there a place for the physician's hopelesness in the treatment of depression?].
    Pitchot W
    Rev Med Liege; 2013 Feb; 68(2):61-4. PubMed ID: 23469485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the Efficacy and Safety of Aripiprazole Versus Bupropion Augmentation in Patients With Major Depressive Disorder Unresponsive to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-Label Study.
    Cheon EJ; Lee KH; Park YW; Lee JH; Koo BH; Lee SJ; Sung HM
    J Clin Psychopharmacol; 2017 Apr; 37(2):193-199. PubMed ID: 28129308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder.
    Fugger G; Bartova L; Dold M; Fabbri C; Fanelli G; Zanardi R; Kautzky A; Zohar J; Souery D; Mendlewicz J; Montgomery S; Rujescu D; Serretti A; Kasper S
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 114():110480. PubMed ID: 34826558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment-resistant depression: A plea to mull over!
    Naguy A; Alamiri B; Al Awadhi DS
    Asian J Psychiatr; 2018 Aug; 36():69-70. PubMed ID: 29979996
    [No Abstract]   [Full Text] [Related]  

  • 39. Improving the care of patients who have treatment-resistant depression: the promise of the PCORnet Mood Network.
    Nierenberg AA; Sylvia L; Doederlein A; Edgman-Levitan S; Muskin A; Jewell L; Walker M; Goodman D; Farahbakhsh M; Hearing C; Tovey R; Deckersbach T
    J Clin Psychiatry; 2015 Apr; 76(4):e528-30. PubMed ID: 25919850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lithium augmentation as an alternative to maintenance electroconvulsive therapy for recurrent major depressive disorder in older adults.
    Wysoczanski D; Cherry S; Spivak V; Lie D; Brisbane DS
    Australas Psychiatry; 2017 Feb; 25(1):84. PubMed ID: 28145138
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.